Entero Therapeutics Inc (ENTO)
0.4533
+0.04
(+9.23%)
USD |
NASDAQ |
Nov 22, 16:00
0.4433
-0.01
(-2.21%)
After-Hours: 20:00
Entero Therapeutics Price to Book Value: 0.2575 for Nov. 22, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 0.2575 |
| November 21, 2024 | 0.2357 |
| November 20, 2024 | 0.2278 |
| November 19, 2024 | 0.2318 |
| November 18, 2024 | 0.2502 |
| November 15, 2024 | 0.2782 |
| November 14, 2024 | 0.2962 |
| November 13, 2024 | 0.3579 |
| November 12, 2024 | 0.3522 |
| November 11, 2024 | 0.3616 |
| November 08, 2024 | 0.3908 |
| November 07, 2024 | 0.3749 |
| November 06, 2024 | 0.3863 |
| November 05, 2024 | 0.405 |
| November 04, 2024 | 0.383 |
| November 01, 2024 | 0.3908 |
| October 31, 2024 | 0.3636 |
| October 30, 2024 | 0.3464 |
| October 29, 2024 | 0.3408 |
| October 28, 2024 | 0.3288 |
| October 25, 2024 | 0.3583 |
| October 24, 2024 | 0.3885 |
| October 23, 2024 | 0.3437 |
| October 22, 2024 | 0.3502 |
| October 21, 2024 | 0.3863 |
| Date | Value |
|---|---|
| October 18, 2024 | 0.42 |
| October 17, 2024 | 0.4131 |
| October 16, 2024 | 0.318 |
| October 15, 2024 | 0.2555 |
| October 14, 2024 | 0.2576 |
| October 11, 2024 | 0.2674 |
| October 10, 2024 | 0.2278 |
| October 09, 2024 | 0.2379 |
| October 08, 2024 | 0.2374 |
| October 07, 2024 | 0.2946 |
| October 04, 2024 | 0.3398 |
| October 03, 2024 | 0.1974 |
| October 02, 2024 | 0.1851 |
| October 01, 2024 | 0.1813 |
| September 30, 2024 | 0.1951 |
| September 27, 2024 | 0.1226 |
| September 26, 2024 | 0.1241 |
| September 25, 2024 | 0.1159 |
| September 24, 2024 | 0.1128 |
| September 23, 2024 | 0.1109 |
| September 20, 2024 | 0.1177 |
| September 19, 2024 | 0.1213 |
| September 18, 2024 | 0.1213 |
| September 17, 2024 | 0.1256 |
| September 16, 2024 | 0.1306 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.0848
Minimum
Aug 08 2024
9.861
Maximum
Jun 09 2020
3.099
Average
2.084
Median
Jan 30 2024
Price to Book Value Benchmarks
| Pulmatrix Inc | 2.047 |
| NovaBay Pharmaceuticals Inc | 3.121 |
| Palatin Technologies Inc | -- |
| iBio Inc | 1.360 |
| Theriva Biologics Inc | 0.1446 |
Price to Book Value Related Metrics
| Price | 0.4533 |
| Earnings Yield | -1.49K% |
| Market Cap | 2.155M |